The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Imaoka, K.
Right arrow Articles by Kiyono, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Imaoka, K.
Right arrow Articles by Kiyono, H.
The Journal of Immunology, 1998, 161: 5952-5958.
Copyright © 1998 by The American Association of Immunologists

Nasal Immunization of Nonhuman Primates with Simian Immunodeficiency Virus p55gag and Cholera Toxin Adjuvant Induces Th1/Th2 Help for Virus-Specific Immune Responses in Reproductive Tissues1

Koichi Imaoka*,{dagger}, Christopher J. Miller{ddagger}, Mitsuru Kubota*, Michael B. McChesney{ddagger}, Barbara Lohman{ddagger}, Masafumi Yamamoto*, Kohtaro Fujihashi*, Kenji Someya§, Mitsuo Honda§, Jerry R. McGhee* and Hiroshi Kiyono2,*

* Immunobiology Vaccine Center and Departments of Oral Biology and Microbiology, University of Alabama, Birmingham, AL 35294; {dagger} Department of Microbiology, National Institute of Public Health, Minato, Tokyo, Japan; {ddagger} California Regional Primate Research Center, University of California, Davis, CA 95615; § AIDS Research Center, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan; and Department of Mucosal Immunology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan

Female rhesus macaques were nasally immunized with p55gag (p55) of SIV and cholera toxin as a mucosal adjuvant. Nasal immunization induced Ag-specific IgA and IgG Abs in mucosal secretions (e.g., cervicovaginal secretions, rectal washes, and saliva) and serum. Furthermore, high numbers of p55-specific IgA and IgG Ab-forming cells were induced in mucosal effector sites, i.e., uterine cervix, intestinal lamina propria, and nasal passage. p55-specific CD4+ T cells in both systemic and mucosal compartments expressed IFN-{gamma} and IL-2 (Th1-type)- as well as IL-5, IL-6, and IL-10 (Th2-type)-specific mRNA. Moreover, p55-specific CTL activity was demonstrated in lymphocytes from blood, tonsils, and other lymphoid tissues. These results show that nasal immunization with SIV p55 with cholera toxin elicits both Th1- and selective Th2-type cytokine responses associated with the induction of SIV-specific mucosal and serum Abs, and CTL activity. These results offer a promise for the development of protective mucosal immunity to SIV.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
D. Medaglini, A. Ciabattini, A. M. Cuppone, C. Costa, S. Ricci, M. Costalonga, and G. Pozzi
In Vivo Activation of Naive CD4+ T Cells in Nasal Mucosa-Associated Lymphoid Tissue following Intranasal Immunization with Recombinant Streptococcus gordonii.
Infect. Immun., May 1, 2006; 74(5): 2760 - 2766.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Gupta, R. Janani, Q. Bin, P. Luciw, C. Greer, S. Perri, H. Legg, J. Donnelly, S. Barnett, D. O'Hagan, et al.
Characterization of Human Immunodeficiency Virus Gag-Specific Gamma Interferon-Expressing Cells following Protective Mucosal Immunization with Alphavirus Replicon Particles
J. Virol., June 1, 2005; 79(11): 7135 - 7145.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Kobayashi, T. Kohda, K. Kataoka, H. Ihara, S. Kozaki, D. W. Pascual, H. F. Staats, H. Kiyono, J. R. McGhee, and K. Fujihashi
A Novel Neurotoxoid Vaccine Prevents Mucosal Botulism
J. Immunol., February 15, 2005; 174(4): 2190 - 2195.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Yoshino, F. X.-S. Lu, K. Fujihashi, Y. Hagiwara, K. Kataoka, D. Lu, L. Hirst, M. Honda, F. W. van Ginkel, Y. Takeda, et al.
A Novel Adjuvant for Mucosal Immunity to HIV-1 gp120 in Nonhuman Primates
J. Immunol., December 1, 2004; 173(11): 6850 - 6857.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. Abel, L. Compton, T. Rourke, D. Montefiori, D. Lu, K. Rothaeusler, L. Fritts, K. Bost, and C. J. Miller
Simian-Human Immunodeficiency Virus SHIV89.6-Induced Protection against Intravaginal Challenge with Pathogenic SIVmac239 Is Independent of the Route of Immunization and Is Associated with a Combination of Cytotoxic T-Lymphocyte and Alpha Interferon Responses
J. Virol., March 1, 2003; 77(5): 3099 - 3118.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Sakaue, T. Hiroi, Y. Nakagawa, K. Someya, K. Iwatani, Y. Sawa, H. Takahashi, M. Honda, J. Kunisawa, and H. Kiyono
HIV Mucosal Vaccine: Nasal Immunization with gp160-Encapsulated Hemagglutinating Virus of Japan-Liposome Induces Antigen-Specific CTLs and Neutralizing Antibody Responses
J. Immunol., January 1, 2003; 170(1): 495 - 502.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. P. Bradney, G. D. Sempowski, H.-X. Liao, B. F. Haynes, and H. F. Staats
Cytokines as Adjuvants for the Induction of Anti-Human Immunodeficiency Virus Peptide Immunoglobulin G (IgG) and IgA Antibodies in Serum and Mucosal Secretions after Nasal Immunization
J. Virol., January 15, 2002; 76(2): 517 - 524.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. Stevceva, B. Kelsall, J. Nacsa, M. Moniuszko, Z. Hel, E. Tryniszewska, and G. Franchini
Cervicovaginal Lamina Propria Lymphocytes: Phenotypic Characterization and Their Importance in Cytotoxic T-Lymphocyte Responses to Simian Immunodeficiency Virus SIVmac251
J. Virol., January 1, 2002; 76(1): 9 - 18.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Fromantin, B. Jamot, J. Cohen, L. Piroth, P. Pothier, and E. Kohli
Rotavirus 2/6 Virus-Like Particles Administered Intranasally in Mice, with or without the Mucosal Adjuvants Cholera Toxin and Escherichia coli Heat-Labile Toxin, Induce a Th1/Th2-Like Immune Response
J. Virol., November 15, 2001; 75(22): 11010 - 11016.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
G. Ada
Vaccines and Vaccination
N. Engl. J. Med., October 4, 2001; 345(14): 1042 - 1053.
[Full Text] [PDF]


Home page
J. Virol.Home page
S. Crotty, C. J. Miller, B. L. Lohman, M. R. Neagu, L. Compton, D. Lu, F. X.-S. Lu, L. Fritts, J. D. Lifson, and R. Andino
Protection against Simian Immunodeficiency Virus Vaginal Challenge by Using Sabin Poliovirus Vectors
J. Virol., August 15, 2001; 75(16): 7435 - 7452.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S.-W. Wang, P. A. Kozlowski, G. Schmelz, K. Manson, M. S. Wyand, R. Glickman, D. Montefiori, J. D. Lifson, R. P. Johnson, M. R. Neutra, et al.
Effective Induction of Simian Immunodeficiency Virus-Specific Systemic and Mucosal Immune Responses in Primates by Vaccination with Proviral DNA Producing Intact but Noninfectious Virions
J. Virol., November 15, 2000; 74(22): 10514 - 10522.
[Abstract] [Full Text]


Home page
J. Virol.Home page
S. Crotty, B. L. Lohman, F. X.-S. Lu, S. Tang, C. J. Miller, and R. Andino
Mucosal Immunization of Cynomolgus Macaques with Two Serotypes of Live Poliovirus Vectors Expressing Simian Immunodeficiency Virus Antigens: Stimulation of Humoral, Mucosal, and Cellular Immunity
J. Virol., November 1, 1999; 73(11): 9485 - 9495.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.